DispersinB
Natural health product licensed in Canada
- Licence holder
- Kane Biotech Inc.
- NPN or DIN-HM
- 80052327
- Status
- Active licence
- Licence date
- 8 July 2014
- Revision date
- 24 November 2014
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Chlorure de sodium, Laureth sulfate de sodium, Alcool cétéarylique, Acide citrique, glycérol, Allantoïne, Cocamidopropopyl bétaïne, Gomme de xanthane, Eau purifiée, Farine d'avoine colloïdale, Trisodium citrate, D-Panthénole, EDTA de sodium, Sorbate de potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve minor skin irritations.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052327
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging